John Brendan Doyle - Chief Financial Officer at Cognition Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CGTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Brendan Doyle since 8/28/2023

Holdings reported by John Brendan Doyle for Cognition Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 121K $236K $1.95 May 1, 2024 Direct
Stock Option (Right to Buy) 20K Feb 15, 2024 Direct Common Stock

Transactions reported by John Brendan Doyle for Cognition Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.